Predict your next investment

HEALTHCARE | Drug Development
vensunrx.com

See what CB Insights has to offer

Total Raised

$48M

Investors Count

5

Deal Terms

2

Vensun Pharmaceuticals Funding, Vensun Pharmaceuticals Valuation & Vensun Pharmaceuticals Revenue

5 Fundings

Vensun Pharmaceuticals's latest funding round was a Acquired for on January 29, 2019.

Vensun Pharmaceuticals's valuation in March 2012 was $20.48M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/29/2019

Acquired

$0.00B

((9.99x))

FY 1234

1

12/1/2016

Series C

$99M

$0.00B

((9.99x))

FY 1234

10

10/7/2015

Debt

$99M

$0.00B

((9.99x))

FY 1234

10

12/19/2013

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

3/28/2012

Series A

$99M

$20.48M

$0.00B

((9.99x))

FY 1234

10

Date

1/29/2019

12/1/2016

10/7/2015

12/19/2013

3/28/2012

Round

Acquired

Series C

Debt

Series B

Series A

Amount

$99M

$99M

$99M

$99M

Investors

Valuation

$20.48M

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

10

10

Vensun Pharmaceuticals Deal Terms

2 Deal Terms

Vensun Pharmaceuticals's deal structure is available for 2 funding rounds, including their Series B from December 19, 2013.

Round

Series B

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

Vensun Pharmaceuticals Investors

5 Investors

Vensun Pharmaceuticals has 5 investors. Strides Consumer invested in Vensun Pharmaceuticals's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/29/2019

1/29/2019

1
Acquired

Corporation

New Jersey

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Asset/Investment Management

New York

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Hedge Fund

New York

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Angel Investor (Individual)

First funding

1/29/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

1/29/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Type

Corporation

Asset/Investment Management

Venture Capital

Hedge Fund

Angel Investor (Individual)

Location

New Jersey

New York

New York

New York

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.